AZN(AstraZeneca PLC) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $37.42B | $44.35B | $45.81B | $54.07B | $58.74B |
| 毛利润 | $24.98B | $31.96B | $37.54B | $43.87B | $48.11B |
| 营业利润 | $1.06B | $3.76B | $8.19B | $10.00B | $13.74B |
| 净利润 | $112.00M | $3.29B | $5.96B | $7.04B | $10.22B |
| 经营现金流 | $5.96B | $9.81B | $10.35B | $11.86B | $14.57B |
| 自由现金流 | $4.87B | $8.72B | $8.98B | $9.94B | $11.77B |
| 摊薄每股收益 | $0.16 | $4.22 | $3.81 | $4.50 | $6.54 |